Urinary 11‐Dehydro‐Thromboxane B2 as a Predictor of Acute Myocardial Infarction Outcomes: Results of Leukotrienes and Thromboxane In Myocardial Infarction (LTIMI) Study

BackgroundUrinary 11‐dehydro‐thromboxane (TX)B2 has been described as a potential predictive biomarker of major adverse cardiovascular events (MACEs) in high cardiac risk patients. This part of LTIMI (Leukotrienes and Thromboxane In Myocardial Infarction) study aimed to evaluate the relationship bet...

Celý popis

Podrobná bibliografie

Hlavní autoři:	Wojciech Szczeklik, Edyta Stodółkiewicz, Marcin Rzeszutko, Marek Tomala, Anton Chrustowicz, Krzysztof Żmudka, Marek Sanak
Médium:	Artigo
Jazyk:	Inglês
Vydáno:	Wiley 2016-08-01
Edice:	Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
Témata:	atherosclerosis complication inflammation myocardial infarction risk factor thromboxane
On-line přístup:	https://www.ahajournals.org/doi/10.1161/JAHA.116.003702
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!